Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma

BMC Ophthalmology

Table 1 Clinical data of patients with IOL

Case No	Sex	Age	Laterality	Extraocular involvement	Cell block cytology	IL-10/IL-6 Ratio > 1	IgH
1	F	63	Bilateral	None	+	+	+
2	M	63	Bilateral	None	+	+	+
3	F	80	Bilateral	None	+	+	+
4	M	82	Bilateral	None	+	+	NA
5	M	75	Unilateral	None	+	+	NA
6	F	72	Bilateral	None	+	+	+
7	M	74	Unilateral	None	+	-	+
8	M	82	Bilateral	None	+	+	+
9	M	58	Bilateral	None	+	+	+
10	F	82	Bilateral	None	+	-	+
11	M	58	Bilateral	None	+	+	+
12	F	49	Unilateral	None	+	+	NA
13	M	47	Bilateral	None	+	+	+
14	M	58	Bilateral	None	+	+	+
15	F	92	Bilateral	None	+	+	+
16	M	85	Bilateral	None	+	+	+
17	F	72	Bilateral	None	+	+	+
18	M	82	Unilateral	CNS, Orbit	NA^a	+	-
19	M	47	Unilateral	CNS, LNs	NA^a	+	-
20	F	54	Unilateral	CNS	+	+	NA
21	M	64	Bilateral	CNS, LNs	+	+	+
22	M	77	Unilateral	CNS, LNs	+	+	-
23	M	73	Unilateral	CNS	+	+	NA
24	M	63	Bilateral	Testes, Nose, LNs	NA^a	+	-
25	M	46	Bilateral	LNs	+	-	+

F Female, M Male, LNs Lymph nodes, CNS Central nerve system, IgH Immunoglobulin-heavy chain rearrangements, NA Not available
^aMalignant lymphoid cells were confirmed with biopsy of extraocular lesions

ISSN: 1471-2415